Core Viewpoint - GSK plc is facing allegations related to misleading statements regarding the withdrawal of Zantac from the market, with claims that the company was aware of the source of NDMA for nearly 40 years before the product's removal [1]. Group 1: Allegations and Legal Context - The class period for the allegations against GSK spans from February 5, 2020, to August 14, 2022 [1]. - Defendants allegedly misrepresented to investors that GSK removed Zantac based on available information and correspondence with regulators, while also claiming that there was no evidence linking ranitidine therapy to cancer [1]. - The complaint asserts that GSK's representations were materially false or misleading, as the company had prior knowledge of the NDMA source [1]. Group 2: Shareholder Actions and Deadlines - Shareholders who purchased GSK shares during the specified class period are encouraged to register for the class action, with a deadline set for April 7, 2025 [2]. - Once registered, shareholders will be enrolled in a portfolio monitoring system to receive updates on the case's progress [2]. - There is no cost or obligation for shareholders to participate in the case [2]. Group 3: Firm's Mission and Commitment - The Gross Law Firm aims to protect the rights of investors affected by deceit and illegal business practices, emphasizing the importance of responsible corporate behavior [3]. - The firm seeks recovery for investors who suffered losses due to false or misleading statements that inflated the company's stock value [3].

Core Viewpoint - The Trade Desk, Inc. is facing a class action lawsuit due to allegations of issuing materially false and misleading statements regarding its AI forecasting tool, Kokai, which has led to execution challenges and negatively impacted revenue growth [1][2]. Group 1: Allegations - The complaint alleges that during the class period from May 9, 2024, to February 12, 2025, The Trade Desk experienced significant self-inflicted execution challenges in rolling out its AI tool, Kokai [1]. - These execution challenges delayed the Kokai rollout, which in turn negatively impacted the company's business operations and revenue growth [1]. - The positive statements made by the defendants about the company's business and prospects were materially false and misleading due to the aforementioned issues [1]. Group 2: Class Action Details - Shareholders who purchased shares of The Trade Desk during the specified class period are encouraged to register for the class action, with a deadline of April 21, 2025, to seek lead plaintiff status [2]. - Once registered, shareholders will be enrolled in a portfolio monitoring software to receive updates throughout the lifecycle of the case [2]. - Participation in the case incurs no cost or obligation for the shareholders [2].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of ModivCare Inc. regarding a class action lawsuit due to alleged misleading statements and concealed information that negatively impacted the company's financial performance [1][2]. Group 1: Allegations and Financial Impact - The allegations state that ModivCare's contracts in the Non-Emergency Medical Transportation (NEMT) segment led to a deterioration in free cash flow [1]. - The complaint claims that contract renegotiations and pricing accommodations adversely affected the company's adjusted EBITDA [1]. - It is also alleged that ModivCare faced liquidity issues and that the defendants' positive statements about the company's business and prospects were materially misleading [1]. Group 2: Class Action Details - The class period for the lawsuit is defined as November 3, 2022, to September 15, 2024 [1]. - Shareholders who purchased shares during this period are encouraged to register for the class action by March 31, 2025, to potentially be appointed as lead plaintiffs [2]. - Participants will be enrolled in a portfolio monitoring software to receive updates on the case's status [2]. Group 3: Law Firm's Mission - The Gross Law Firm is recognized nationally for its commitment to protecting investors' rights against deceit and fraud [3]. - The firm aims to ensure that companies engage in responsible business practices and good corporate citizenship [3]. - The firm seeks recovery for investors who suffered losses due to misleading statements or omissions that inflated the company's stock value [3].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of FMC Corporation regarding a class action lawsuit due to alleged misleading statements and failure to disclose critical information during a specified class period [1][3]. Summary by Relevant Sections Class Period and Allegations - The class period for the lawsuit is from November 16, 2023, to February 4, 2025 [3]. - Allegations include: 1. The company's channel management initiatives were not progressing as claimed [3]. 2. The company chose not to compete on prices due to pricing pressure, resulting in missed sales opportunities [3]. 3. There was inflated inventory in channels across Latin America (including Brazil), Asia (including India), Canada, and Eastern Europe [3]. 4. Positive statements made by the defendants regarding the company's business and prospects were materially misleading and lacked a reasonable basis [3]. Next Steps for Shareholders - Shareholders are encouraged to register for the class action by April 14, 2025, to potentially become lead plaintiffs [4]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's status [4]. Law Firm's Commitment - The Gross Law Firm aims to protect investors' rights against deceit and fraud, ensuring companies adhere to responsible business practices [5].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Quantum Computing Inc. (NASDAQ: QUBT) regarding a class action lawsuit due to alleged misleading statements and omissions made by the company during the class period from March 30, 2020, to January 15, 2025 [1]. Allegations - The complaint alleges that QCI overstated the capabilities of its quantum computing technologies, products, and services [1]. - It is claimed that QCI exaggerated the nature and scope of its relationship with NASA, including contracts and subcontracts [1]. - The company allegedly overstated its progress in developing a thin film lithium niobate (TFLN) foundry and the scale of its operations related to TFLN chips [1]. - QCI's business dealings with Quad M and millionways are said to qualify as related party transactions, which were not disclosed [1]. - The revenues of QCI were reportedly reliant on undisclosed related party transactions, which could negatively impact the company's business and reputation once revealed [1]. - The public statements made by QCI were deemed materially false and misleading throughout the relevant period [1]. Next Steps for Shareholders - Shareholders who purchased QUBT shares during the specified timeframe are encouraged to register for the class action by April 28, 2025 [2]. - Upon registration, shareholders will be enrolled in a portfolio monitoring software to receive updates on the case [2]. - Participation in the case incurs no cost or obligation for the shareholders [2]. About the Gross Law Firm - The Gross Law Firm is a nationally recognized class action law firm focused on protecting the rights of investors affected by deceit, fraud, and illegal business practices [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions [3].

NEW YORK, March 3, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Merck & Co., Inc. (NYSE: MRK).Shareholders who purchased shares of MRK during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/merck-co-inc-loss-submission-form/?id=132974&from=4 CLASS PERIOD: February 3, 2022 to Febru ...

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Monolithic Power Systems Inc. regarding a class action lawsuit due to alleged misleading statements and quality control issues affecting the company's products [1][2]. Summary by Sections Allegations - The complaint alleges that during the class period from February 8, 2024, to November 8, 2024, Monolithic Power Systems made materially false and misleading statements [1]. - Specific allegations include significant performance and quality control issues with Monolithic's voltage regulator modules and power management integrated circuits [1]. - These defects reportedly impacted the performance of products from Monolithic's largest customer, Nvidia, and the relationship between Monolithic and Nvidia has been irreparably damaged [1]. Class Action Details - Shareholders who purchased shares of MPWR during the specified class period are encouraged to register for the class action, with a deadline of April 7, 2025, to seek lead plaintiff status [2]. - Participants will be enrolled in a portfolio monitoring software to receive updates throughout the case lifecycle [2]. Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and illegal business practices [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [3].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Semtech Corporation regarding a class action lawsuit due to alleged misleading statements and omissions related to the company's CopperEdge products [1][2]. Group 1: Allegations - The complaint alleges that during the class period from August 27, 2024, to February 7, 2025, Semtech's CopperEdge products did not meet the needs of its server rack customers or end users [1]. - It is claimed that the CopperEdge products required certain architectural changes in server racks, which were not disclosed [1]. - As a result of these issues, the sales of CopperEdge products are expected to be lower than anticipated, impacting the company's performance in fiscal 2026 [1]. Group 2: Class Action Details - Shareholders who purchased shares of Semtech during the specified class period are encouraged to register for the class action, with a deadline set for April 22, 2025 [2]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the status of the case [2]. - There is no cost or obligation for shareholders to participate in this class action [2]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors who have suffered losses due to deceit and illegal business practices [3]. - The firm aims to ensure that companies adhere to responsible business practices and seeks recovery for investors affected by misleading statements that inflate stock prices [3].

Core Viewpoint - Atkore Inc. is facing allegations of engaging in an anticompetitive price-fixing scheme that artificially inflated the price of PVC Pipes, leading to significant financial benefits that were unsustainable [1] Summary by Sections Allegations - The complaint against Atkore claims that during the class period from February 1, 2024, to February 3, 2025, the company made materially false and misleading statements [1] - Specific allegations include: 1. Atkore's involvement in a price-fixing scheme for PVC Pipes [1] 2. The company benefitted financially from this conduct [1] 3. The exposure of the scheme led to a substantial decrease in PVC Pipe prices [1] 4. Atkore's business operations were negatively impacted as a result [1] 5. Positive statements made by the company regarding its business and prospects were misleading [1] Next Steps for Shareholders - Shareholders who purchased shares of Atkore during the specified timeframe are encouraged to register for the class action by April 23, 2025 [2] - Registration allows shareholders to receive updates on the case through portfolio monitoring software [2] Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and illegal business practices [3] - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [3]

Core Viewpoint - Novo Nordisk A/S faced a significant drop in stock price following the announcement of disappointing results from their "REDEFINE 1" trial, which investigated the efficacy of CagriSema for weight loss [1] Summary by Relevant Sections Class Action Notice - Shareholders who purchased shares of Novo Nordisk (NVO) between November 2, 2022, and December 19, 2024, are encouraged to contact the Gross Law Firm regarding potential lead plaintiff appointment [1] - The class action is in response to allegations stemming from the trial results announced on December 20, 2024 [1] Trial Results - The "REDEFINE 1" trial showed that patients treated with CagriSema experienced a weight loss of 22.7% after 68 weeks, which was below the company's target of at least 25% [1] - Only 57.3% of patients were on the highest dosage during the trial, as they were allowed to modify their own dosage [1] Stock Price Impact - Following the announcement of the trial results, Novo's stock price fell by $18.44 per share, closing at $85.00 per share [1]